Objectives: This study tested the hypothesis that supplementation with galactose before and during endurance exercise would spare carbohydrate (CHO), optimize fat utilization and improve performance compared with a typical sports drink formulation. Subjects: Nine well-trained cyclists undertook three trials, each consisting of 120 min at 65 VO 2max followed immediately by a set work, self-paced time trial (TT). Three treatments, allocated as a randomized balanced design, consisted of the following: (a) 8% (w/w) solution of galactose (Gal); (b) 8% solution of 50% galactose/50% glucose (Gluc/Gal); and (c) 8% solution of 80% glucose/20% fructose (Gluc/Fru). These were consumed as 0.67 g CHO per kg body wt 45-min pre-exercise; 1.0 g CHO per kg body wt per h for the first 120 min of exercise; 0.33 g CHO per kg body wt during the TT. Blood samples were collected before and during exercise; respiratory gas samples were collected only during fixed workload exercise. Results: Mean TT power output was significantly less in Gal compared with Gluc/Gal (P ¼ 0.030). Blood glucose and insulin concentrations were lower, and free fatty acids higher in Gal compared with Gluc/Gal and Gluc/Fru. Respiratory exchange ratio was not significantly different between trials. Conclusions: Ingestion of an 8% galactose-only solution (12.5 ml per kg body wt per h) is detrimental to endurance performance compared with equivalent volumes of iso-osmotic solutions containing 50% galactose/50% glucose or 80% glucose/20% fructose. This may reflect the inability of the liver to convert galactose into glucose at a rate required to support strenuous exercise intensity.
Introduction
Galactose ingestion or infusion produces little glycaemic response (Royle et al., 1978; Gannon et al., 2001) or no insulinogenic activity (Ganda et al., 1979) . The former because it undergoes hepatic metabolism before release as glucose, and the latter because the pancreas is insensitive to increasing blood galactose concentrations (Williams, 1986) .
Unlike when a high glycaemic index (GI) meal is ingested pre-exercise, a low-GI galactose-based meal should not produce hyperinsulinaemia and accompanying hypoglycaemia often seen during the onset of exercise (Hawley and Burke, 1997) . Although this transient hypoglycaemia is not associated with impaired performance (Hawley and Burke, 1997) , low-GI pre-exercise meals are associated with improved endurance compared with high GI (Thomas et al., 1991; DeMarco et al., 1999; Kirwan et al., 2001; Wu and Williams, 2006) . This ergogenic effect may result from an increased availability of circulating free fatty acids (FFAs), attenuated utilization of endogenous carbohydrate (CHO) stores and delayed release of CHO (as glucose) from the gut into the circulation. Accordingly, pre-exercise ingestion of a galactose-based sports drink with its negligible insulin response and slow conversion into glucose may similarly benefit endurance performance compared with a high-GI sports drink.
The performance effects of a CHOs GI ingested during exercise is not well known. A rapid rate of exogenous CHO absorption should benefit strenuous endurance exercise performance (Coyle et al., 1983 (Coyle et al., , 1986 . Conversely, elevated insulin during exercise blunts lipolysis and encourages circulating CHO utilization (Glisezinski et al., 1998; Horowitz et al., 1999) . During prolonged exercise, maintenance of lipid oxidation while CHO is still being absorbed should preserve that CHO for latter use. Given the importance of circulating CHO in maintaining power output in the latter stages of prolonged exercise when muscle glycogen stores become lowered (Gollnick et al., 1981; Bosch et al., 1996) , sparing CHO by oxidizing more lipid in the earlier stages of exercise should be advantageous for endurance performance. The theoretical advantage of galactose ingestion during exercise is that it is being absorbed at the same rate as glucose (Holdsworth and Dawson, 1964 ), yet its necessary conversion in the liver means that its release as glucose into the blood stream will be delayed. A galactose-based sports drink may therefore prove beneficial to performance compared with current high-GI formulations, if ingested prior to and during prolonged exercise.
Only three studies have investigated the ingestion of galactose on endurance performance. One employed a 20-min warm up at 65% maximal oxygen uptake (VO 2max ) followed by a self-paced time trial (TT) of B40 min (Jentjens and Jeukendrup, 2003) . No effect of galactose ingestion on performance was apparent. In contrast, others (King et al., 2006) observed improved endurance at 90% maximal power output (W max ) (following a 20-min incremental warm up, then 10 90-s intervals at 90% W max ) with galactose ingestion. Finally, Sharoff et al. (2006) observed no difference in performance at 90% W max after a 50-min constant work period (at 60% VO 2max ). During the exercise of the nature and duration described above, CHO stress is unlikely to limit performance, and factors such as muscle buffer capacity are arguably more important (Weston et al., 1997) . The effect of galactose supplementation on exercise performance of a longer duration remains to be investigated.
The purpose of this study was to compare a glucose/ fructose-based sports drink formulation with galactose ingestion on cycling performance of duration similar to that of many cycling road races.
Methods

Subjects
Nine male cyclists (3378 years (mean7s.d.), 73.975.8 kg, VO 2max 5.2770.6 l min
À1
) participated in the study. Each was informed of the experimental procedures before providing a written consent. The protocol was approved by the Massey University Human Ethics Committee.
Pre-experimental protocol Subjects initially attended the laboratory to measure their VO 2max as described previously (Conway et al., 2003) . All exercise testing was performed on an electronically braked cycling ergometer (Lode Excalibur Sport, Groningen, The Netherlands). A linear relationship between submaximal oxygen consumption and power was developed and used to calculate workloads that would elicit 65 and 80% of the measured VO 2max .
Experimental protocol
Subjects arrived at the laboratory after an overnight fast, having avoided exercise for 48 h except for 60-min cycling at the 65% VO 2max test workload the previous day. Food intake during the previous 24 h was recorded, and subjects repeated this diet before subsequent tests. The lab-controlled training and food diaries were administered to ensure similarities in glycogen status prior to each performance test.
Before each trial, a cannula was inserted into a forearm vein, and a 6-ml blood sample (À45 min) was obtained. An initial bolus of test drink was administered, then the subject remained seated for 45 min. Further blood samples were collected just prior to the beginning of exercise (0 min).
Exercise began with a 120-min trial at a fixed intensity (65% VO 2max ), where work rate was independent of cadence. At 120 min, the ergometer changed to linear mode (where workload is proportional to cadence), and a self-paced TT was performed. The TT required completion of a target amount of work (kJ) equivalent to 80% VO 2max for 30 min. Subjects were aware of the end point and encouraged to complete the TT as quickly as possible.
During testing, ambient temperature, humidity and wind speed were held constant (22 1C, 50% and 24 km h À1 , respectively).
Treatments
The three treatments (test drinks) were administered in a double-blinded fashion. Treatment drinks contained either of the following: (A) glucose 80% and fructose 20% (Gluc/ Fru); (B) glucose 50% and galactose 50% (Gluc/Gal); or (C) 100% galactose (Gal). To minimize ordering effects, six subjects were assigned randomly to one of three test sequences (A-B-C, B-C-A, C-A-B, A-C-B, C-B-A and B-A-C), while three were assigned (A-B-C, B-C-A and C-A-B).
The drinks provided a solution of 8% CHO (w/w) and were balanced for osmolality. The volume of the drink provided was calculated to provide 1 g of CHO per kg body weight per hour during the first 120 min of exercise. For example, a 72-kg rider ingested 900 ml of solution each hour at 300 ml per 20-min period.
The initial bolus of test drink (at À45 min) was twice the volume of each 20-min drink described above. A final drink (same as the 20-min drinks above) was ingested during the TT.
Tests were administered on the same day of the week, with an interval of 7 or 14 days in between.
Blood sampling Blood samples were obtained at 5, 10, 20, 40, 60, 80, 100 and 120 min and just before the completion of the TT. A capillary tube was quickly filled with the blood from the collection tube for immediate analysis of whole-blood lactate concentration.
Gas analysis Expired respiratory gas samples were obtained just prior to the collection of each blood sample. These were collected and analysed as described previously (Stannard et al., 2007) .
Biochemical analyses
Blood lactate concentration was determined using a lactate auto-analyser (YSI, Yellow Springs, OH, USA). Plasma FFA, and serum insulin and glucose concentrations were analysed using methods described by Stannard et al. (2007) .
Statistical analyses
Data were divided into resting and exercise. Resting data included À45-min (fasting) and 0-min blood samples. Exercise data included blood and respiratory gas samples obtained during exercise. Blood samples were analysed in duplicate, and the mean recorded for statistical analyses.
Time trial performance and blood samples taken just before the end of the TT were compared using a one-way (for treatment) repeated measures analysis of variance based on a General Linear Model. Respiratory gas and blood data were compared using a two-way repeated measures (for treatment and time) analysis of variance. In the case of a significant main effect of treatment, post hoc testing was performed to identify which treatments were significantly different from each other.
All statistical analyses were performed using specialist statistical software (SPSS Version 10). Significance was ascribed at a confidence level of 95% (Pp0.05).
Results
In two subjects, a total of three exercising blood samples could not be collected due to blockage of the cannula. To enable repeated measures statistical analysis, including these participants, missing values were replaced with the mean of the value on either side.
One subject stopped for 90 s during the initial portion of his first trial to urinate. An identical stoppage period was then included during his subsequent tests. Notably, another five subjects indicated that they had a fuller bladder during the Gal-only trial.
Rest
Blood analyses. As expected, changes in plasma glucose concentrations over the 45-min pre-exercise rest period differed between treatments (treatment * time interaction, P ¼ 0.003). Gal resulted in a slight drop in plasma glucose concentration over the 45-min time period, while the other two treatments produced an increase in glucose concentration over this time period (Figure 1d) .
Serum insulin concentration significantly increased during resting in both Gluc/Fru and Gluc/Gal (Po0.001), but did not change from basal levels in Gal (Figure 1c ). There was no significant difference in the increase in insulin between Gluc/Fru and Gluc/Gal in this period.
Lactate significantly increased during the 45-min time period (P ¼ 0.001), and this increase was similar for all treatments (treatment * time interaction, P ¼ 0.609) (Figure 1b) .
In contrast, plasma FFA concentrations decreased during this resting period (Po0.001), and again this decrease was similar for all treatments (treatment * time interaction, P ¼ 0.271) (Figure 1a) .
Submaximal steady-state exercise Expired respiratory gases. In all trials, VO 2max increased with exercise duration (P ¼ 0.028). However, this increase was not significantly different between trials (P ¼ 0.688), nor was there a main effect of treatment on VO 2max during exercise (P ¼ 0.261). Mean percentage of VO 2max was 67.3, 65.9 and 66.9 for the Gal, Gal/Gluc and Fru/Gal trials, respectively. Overall, respiratory exchange ratio (RER) declined with exercise time (Po0.001), although this decline was not modulated by treatment conditions (P ¼ 0.312). There was no main effect of treatment on exercising RER (P ¼ 0.178) ( Table 1 ).
Blood analyses. There was a highly significant interaction between plasma glucose concentration and time (Po0.001). During the Gal trial, blood glucose concentrations remained stable after an initial rise during the first 20 min of exercise. However, in the other two trials, a drop at the beginning of exercise was followed by a rise, which reached maximal/peak levels that were sustained for the rest of the submaximal portion of the exercise trial. A main effect of treatment neared significance (P ¼ 0.06).
A significant interaction between treatment and time existed for serum insulin concentration during constantload exercise at 65% VO 2max (P ¼ 0.023). There were also highly significant main time and treatment effects (both Po0.001), such that in all trials, insulin concentration declined during the first 10 min of exercise followed by a rise at 40 min before continuing to decline for the remainder of the constant-load portion of the exercise trial. During the Gal trial, this response was blunted in comparison to the other two trials and serum insulin remained lower than in either Gal/Gluc or Glu/Fru.
Whole blood lactate concentration decreased over time in all trials during constant-load exercise (Po0.001), but the rate of decrease was not significantly different between trials (treatment * time interaction, P ¼ 0.090). There was no main effect of the treatment on blood lactate concentration (P ¼ 0.509).
Plasma FFA concentration increased in all trials during constant-load exercise with a marked increase occurring 60 min after the onset of exercise (Po0.001). This increase was significantly greater in the Gal trial (Po0.001). A main effect of the treatment was also apparent (P ¼ 0.004).
Time trial
Time to complete the required work amount for the TT was significantly different between treatments (P ¼ 0.009). Post hoc contrasts revealed that during the Gal trial, participants were significantly slower than during both the Gluc/Gal (P ¼ 0.016) and Gluc/Fru trials (P ¼ 0.036). However, these comparisons repeated with Bonferroni correction (for 95% confidence) observed only a significant difference between Gal and Gluc/Gal (P ¼ 0.049). The variance in the Gluc/Gal response meant that the performance comparison between Gal and Gluc/Fru did not reach significance (P ¼ 0.107).
Mean TT power output showed a significant effect of treatment (P ¼ 0.005). Post hoc tests with Bonferroni correction revealed only significant difference between Gal and Gluc/Gal (P ¼ 0.03), while the difference between Gal and Gluc/Fru neared significance (P ¼ 0.065) (Figure 2) .
Due to the clotting of the cannula, insufficient blood was obtained within the final minute of the TT to allow analysis of all variables.
Plasma glucose concentration in the final minute of the TT was significantly higher in Gluc/Fru compared with Gal (P ¼ 0.015), and although it was also higher in Gluc/Gal, this did not reach significance (P ¼ 0.107) (data from eight subjects only).
Discussion
This study was designed to investigate the utility of galactose as a sports drink supplement on endurance cycling performance. Even with a low statistical power as a result of the relatively small subject numbers, the (negative) effect (size) of ingesting galactose alone was sufficient for us to observe a significant decrement in performance. Despite promoting a lesser insulin response and a greater availability of plasma FFAs, ingestion of an 8% galactose solution (12.5 ml per kg body wt per h) alone cannot support self-paced cycling work rate (after 120 min of fixed-load cycling) at the level that can Figure 1 Venous blood concentrations of (a) plasma free fatty acids (FFAs); (b) blood lactate; (c) serum insulin; and (d) plasma glucose during the 45-min rest immediately prior to exercise and during the 2-h submaximal steady-state exercise at 65% maximal oxygen uptake (VO 2max ). Abbreviations: TT, time trial; VO 2max , maximal oxygen uptake.
be supported by equivalent ingestion of solutions containing concentrations of either 50% galactose/50% glucose or 80% glucose/20% fructose. Respiratory gas analysis did not reveal any significant difference in proportional substrate selection during the submaximal portion of the exercise trials. Thus, the ergolytic effect of galactose ingestion was not due to reduced CHO utilization by the muscle, at least during the first 2 h. It is possible that during this part of the test, intensity was such that muscle glycogen remained the primary substrate, so that altering the circulating metabolic mix did not alter oxidation. Previous work has shown that only when muscle glycogen stores become low does changing the availability of circulating substrate (plasma glucose or FFA) alter substrate selection (Pernow and Saltin, 1971; Gollnick et al., 1981; Bosch et al., 1996) . It is then also possible that during the TT increased circulating glucose availability during Gluc/Gal and Gluc/Fru may have enabled higher work rates. Certainly, plasma glucose concentration was lower in the Gal trial at the completion of the TT. Although circulating FFA availability was significantly higher during the initial 120 min of Gal, any increased FFA availability during the TT may have been unable to offset the endogenous CHO requirement necessary to sustain higher workloads. However, this explanation remains speculative, as respiratory gas and blood measurements were not made during the TT. To do so would have hampered the participants' ability to focus on the task of riding as hard as possible.
Blood glucose concentration in the latter stages of the 120-min submaximal portion of Gluc/Fru or Gluc/Gal was significantly higher than Gal despite plunging lower at exercise onset. This oft-observed phenomenon occurs when a high-GI CHO is ingested prior to the onset of exercise and results from the addition of insulin-mediated glucose uptake and contraction-mediated glucose uptake by muscle. Despite blood glucose in both the Gluc/Gal and Gluc/Fru trials transiently dropping to levels below that seen after 120 min of the Gal trial, there was no indications of undo fatigue at this time nor subsequent detriment to performance. These observations concur with others who have also shown that pre-exercise ingestion of CHO, while producing transient hypoglycaemia, is not ergolytic (Hawley and Burke, 1997) .
No participants complained of gastrointestinal distress or diarrhoea during or after any of the trials, suggesting that the rate of CHO administration did not exceed absorption. Indeed that blood glucose rebounded following transient hypoglycaemia in Gluc/Gal suggests that the rate of glucose absorption from this drink (4% glucose concentration) was sufficient to maintain higher levels of glycaemia than the Gal trial. Without knowledge of the contribution of hepatic glucose release to blood glucose concentration, we are unable to determine whether the relatively greater level of glycaemia observed in Gluc/Gal and Gluc/Fru trials was only due to a higher rate of intestinal glucose release. However, because serum insulin concentrations were higher, and because insulin inhibits hepatic glucose release, it is reasonable to assume that the availability of glucose was greater in Gluc/Gal and Gluc/Fru because glucose was directly released from the gut.
Rates of glucose and galactose absorption are similar because uptake of both monosaccharides requires an identical transport protein (Shils and Young, 1988) . Previous work shows that during exercise of an equivalent work rate (65% VO 2max ) galactose ingestion at 0.64 g kg À1 h À1 cannot be processed by the liver at the rate it is absorbed (Leijssen et al., 1995) . Accordingly, Leijssen et al. (1995) observed a steady increase in blood galactose concentration over 120 min, and at the same time blood glucose concentration remained significantly lower compared to when the same amount of glucose alone was ingested. Observations of the present study, in combination with the results of Leijssen et al. (1995) suggest that the rate at which the liver can process galactose is not sufficient to maintain optimal levels of glycaemia during the latter stages of prolonged exercise. In contrast, a combination of glucose and galactose was able to support circulating glucose concentrations that enabled higher levels of exercise intensity. An interesting observation was the feeling of bladder fullness during the Gal trial. This cannot be properly explained without data describing blood galactose concentrations or urinary sampling. However, as there is no renal threshold for galactose excretion and tubular reabsorption is less efficient than for glucose (Williams, 1986) , an increased blood galactose concentration consistent with the rate of ingestion in the present study (Leijssen et al., 1995) probably caused this polyuria.
Conclusion
Ingestion of an 8% galactose-only sports drink at 12.5 ml per kg body wt per h was detrimental to endurance cycling Figure 2 Time taken to complete the set work, self-paced cycling time trial immediately following 120 min of prior cycling exercise at 65% maximal oxygen uptake (VO 2max ) during which time isoosmotic 8% (w/w) solutions of glucose/fructose (80:20) (Gluc/Fru); galactose/glucose (50:50) (Gluc/Gal); and galactose (Gal) were consumed. *Significantly different from Gal (Po0.05).
performance compared with equivalent volumes of isoosmotic solutions containing 50% galactose/50% glucose or 80% glucose/20% fructose. This result may reflect insufficient circulating CHO availability when galactose is substituted for glucose in the ingested solution. This, in turn, may be due to hepatic galactose to glucose conversion insufficient to support hepatic glucose release at a rate required to sustain higher cycling power outputs.
